ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading&nbsp ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading 

Posted on by Raj Gaurav Rai

ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading&nbsp ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading 

Please follow and like us:
fb-share-icon
Tweet
Pin Share

Related Posts

Important Update for F&O Traders!NSE has revised contract sizes for index derivatives, effective Nov 20, 2024. Key changes:– Nifty 50: 25 to 75 – Nifty Bank: 15 to 30 – Nifty Financial Services: 25 to 65 – Nifty Midcap Select: 50 to 120 – Nifty Next 50: 10 to 25 Important Update for F&O Traders!NSE has revised contract sizes for index derivatives, effective Nov 20, 2024. Key changes:– Nifty 50: 25 to 75 – Nifty Bank: 15 to 30 – Nifty Financial Services: 25 to 65 – Nifty Midcap Select: 50 to 120 – Nifty Next 50: 10 to 25

Important Update for F&O Traders! NSE has revised contract sizes for index derivatives, effective Nov 20, 2024. Key changes: – Nifty 50: 25 to 75– […]